Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation
Khavinson V, Linkova N, Dyatlova A, Kantemirova R, Kozlov K · 2023 · Cells 12(1):106 (2023 issue; online December 2022). DOI 10.3390/cells12010106
What does this source report?
Discusses KED and AEDR. The reported AEDR rat-infarction benefit cites US patent 7,662,789 as reference 123; it is not presented here as a newly recovered peer-reviewed animal trial.
- Population and setting
- Cardiovascular senescence, cell models and animal research
- Evidence type
- Review
- Preparation
- See the original report; formulation details require verification.
- Source language
- English
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Claims about AEDR detection in heart complex are review-reported; original analytical evidence remains a recovery target.
- Patent examples and experimental biomarkers do not establish clinical cardiovascular protection.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Full-text XML checked, including AEDR discussion and patent reference 123.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Khavinson V, Linkova N, Dyatlova A, Kantemirova R, Kozlov K. Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation Cells 12(1):106 (2023 issue; online December 2022). DOI 10.3390/cells12010106 2023.
Molekul research summary: https://molekul.io/research/bio-36611900. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entryRelated compound profiles
Cardiogen
The AEDR rat-infarction finding traces to a patent cited by the cardiovascular review. The molecular link to heart complex remains review-reported here.
Vesugen
A peptide research entry in the Khavinson evidence map. Direct studies, related extract findings, institute reports and unresolved claims are distinguished below.
KED
A tripeptide research entry connected to experimental neurodegeneration work. No human benefit is inferred from mouse-model findings.